Loading...
Images of Jostein Dahle
(0 from 0 )1
0
0
News
Nordic Nanovector ASA 0R6Y (UK - Wall Street Journal
www.wsj.com
The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, and is headquartered in Oslo, Norway. › quotes › xlon › company-people
Nordic Nanovector Announces Presentation of WTOK
www.wtok.com
9 Mar — Jostein Dahle, Co-founder and CSO of Nordic Nanovector, commented: "The pre-clinical data that we have amassed on Alpha37 is taking us ... › prnewswire › › no...
Telephone & Addresses
Jostein Dahle, 77, Bensenville, w692 Crest Ave
View Jostein's social profiles and photos on Facebook, MySpace, and +40 Networks.
WhitePages: Jostein Dahle | Whitepages
View phone numbers, addresses, public records, background check reports and possible arrest records for Jostein Dahle. Whitepages people search is the most trusted directory. Sign up to gain access to mobile numbers, public records, and more.
Network Profiles
LinkedIn: Jostein Dahle - CSO - Nordic Nanovector AS | LinkedIn
Visualizar o perfil de Jostein Dahle no LinkedIn, a maior comunidade profissional do mundo. Jostein tem 7 empregos no seu perfil. Visualize o perfil completo no ...
Interests
Nordic Nanovector: Re Mandatory Notification of Trade
www.businesswire.com
8 Dec — Jostein Dahle's share sale was made under the de minimis exception and was conducted to finance personal obligations. This information was ... › news › home › Nordic-...
Nordic Nanovector ASA - allocation of PSUs - PR Newswire
www.prnewswire.com
11 Mar — Jostein Dahle, CSO was granted 55,000 PSUs. Jostein Dahle now holds 152,233 PSUs, 45,000 options and 204,958 shares including shares to ... › news-releases › nordic-n...
Nordic Nanovector ASA: Betalutin® Continues to Show Promising...
www.businesswire.com
... LA, USA) by Dr. Jostein Dahle, Nordic Nanovector's Chief Scientific Officer. A conference call to discuss the results will be held on Monday
Goodwin Biotechnology Expands its ADC Capabilities with a High...
www.prnewswire.com
"We have built a very productive relationship with Goodwin Biotechnology over the past 18 months," said Jostein Dahle PhD, Chief Scientific ...
Management & Stakeholders
Business Profiles
Researchgate: Jostein Dahle
Oslo, Norway
Jostein DAHLE - Nordic Nanovector AS, Oslo - ResearchGate
www.researchgate.net
› Nordic Nanovector AS
Biography of Jostein Dahle - The Official Board
www.theofficialboard.com
Jostein Dahle is currently Chief Scientific Officer at Nordic Nanovector. At Nordic Nanovector, Jostein Dahle has 15 colleagues including Luigi Costa (CEO), Gisela ...
Education
Jostein Dahle - Biography
www.marketscreener.com
Jostein Dahle founded Nordic Nanovector ASA. Currently, Dr. Dahle is Chief Scientific Officer at this company.
Dr. Dahle received a doctorate from the...
Books & Literature
Acta Oncologica - Taylor and Francis
www.tandfonline.com
Johan Blakkisrud · ORCID Icon , ; Ayca Løndalen ·, ; Jostein Dahle ·, ; Anne Catrine Martinsen ·, ; Arne Kolstad · &. › ... › Volume 60, Issue 11
Anti-CD37 radioimmunotherapy with 177 Lu-NNV PLOS
journals.plos.org
29 Apr — Jostein Dahle. Roles Conceptualization, Funding acquisition, Methodology, Project administration, Resources, Supervision, Writing – review & ... › plosone › article › authors › j...
AACR Proceedings: Part A Online-Only and April 10
books.google.co.uk
Jostein Dahle,1 Amal Saidi,2 Tania Stallons,3 Helen Heyerdahl,1 Ada Repetto-Llamazares,1 Julien Torgue3. 1Nordic Nanovector ASA, Oslo, Norway; ...
Advances in Biological Understanding of Tumor Radiation ...
books.google.co.uk
... Francesco Bertoni 3, Jostein Dahle 2, Randi G. Syljuåsen 1 and Sebastian Patzke 1,2* 1 Department of Radiation Biology, Institute for Cancer Research, ...
Related Documents
Annual Report Cision
mb.cision.com
23 Mar — Betalutin® was invented by Dr Roy H Larsen, Professor Øyvind S Bruland and Dr Jostein Dahle y. 1st patent application was filed for ... › Main
CiteSeerX — Reprints and Subscriptions Permissions
citeseerx.ist.psu.edu
BibTeX @MISC{Dahle_reprintsand, author = {Jostein Dahle and Egil Kvam and Contact The Aacr and Jostein Dahle and Egil Kvam}, title = {Reprints and Subscriptions ...
Scientific Publications
Fractionated therapy of HER2-expressing breast and ovarian ...
pubmed.ncbi.nlm.nih.gov
by H Heyerdahl · · Cited by 55 — Authors. Helen Heyerdahl , Nasir Abbas, Ellen Mengshoel Brevik, Camilla Mollatt, Jostein Dahle. Affiliation. 1 Department of Radiation Biology, ... › ...
Gap Junctional Intercellular Communication Is not a Major jstor
www.jstor.org
the Bystander Effect in Photodynamic Treatment of MDCK II Cells. Jostein Dahle,a,1 Svein-Ole Mikalsen,b Edgar Rivedalb and Harald B. Steena a Department ...
Publications
Targeting B-cell malignancies with the beta-emitting anti ...
link.springer.com
by AF Maaland · · Cited by 11 — Jostein Dahle, Helen Heyerdahl, Adam O'Shea and Véronique Pascal are employees and shareholders of Nordic Nanovector ASA. › article
Reports & Statements
Wikipedia: Øyvind S. Bruland – Wikipedia
I samarbeid med blant andre strålebiologen Jostein Dahle har Larsen og Bruland utviklet medisin mot lymfekreft som de forsøker kommersialisert i selskapet ...
Interview | Nordic Nanovector Investors
nanoinvestors.wordpress.com
Posts about Interview written by savepiginvest
Miscellaneous
212 Pb-NNV003 as a Novel Targeted Alpha Therapy for CD
www.jmirs.org
by A Saidi · · Cited by 1 — Dr. Jostein Dahle. Jostein Dahle. Affiliations. Nordic Nanovector. Search for articles by this author. DOI:https://doi.org j.jmir › article › fulltext
Biodistribution and dosimetry of (177)Lu-tetulomab, a new ...
europepmc.org
by AH Repetto-Llamazares · · Cited by 45 — Jostein Dahle and Ada Repetto are employees of Nordic Nanovector AS. Roy H. Larsen is a stock owner in Nordic Nanovector AS. Michael Lassmann is member of ... › article › med
Company Information - Nordic Nanovector ASA
www.hl.co.uk
Chief Technology Officer; Jostein Dahle Chief Scientific Officer; Gabriele Elbl Vice President - Global Regulatory Affairs; Rosemarie Corrigan › shares › shares-search-results › c...
Cooperative effects of photodynamic treatment of cells PNAS
www.pnas.org
by J Dahle · · Cited by 65 — ... effects of photodynamic treatment of cells in microcolonies. Jostein Dahle, Olav Kaalhus, Johan Moan, and Harald B. SteenAuthors Info & Affiliations. › doi › abs › pnas
Development of Betalutin as a new treatment for Malignant ...
prosjektbanken.forskningsradet.no
6 Sept — ... EANM Meeting in October and will be published in We are also working on two papers on the phase 1 study. Jostein Dahle CSO. › FORISS
Development of next generation radioimmunotherapies of non ...
www.duo.uio.no
by AF Maaland · — Astri Fjelde Maaland, Helen Heyerdahl,Adam O'Shea, Bergthora Eiriksdottir, Véronique Pascal, Jan Terje Andersen, Arne Kolstad, and Jostein Dahle. › handle
Evaluating Antigen Targeting and Anti-tumor Activity of a New ...
ar.iiarjournals.org
JOSTEIN DAHLE, ADA H.V. REPETTO-LLAMAZARES, CAMILLA S. MOLLATT, KATRINE B. MELHUS, ØYVIND S. BRULAND, ARNE KOLSTAD and ROY H. LARSEN. › content › tab-figures-data
Experimental α-particle radioimmunotherapy of breast cancer ...
ejnmmires.springeropen.com
by N Abbas · · Cited by 61 — Nasir Abbas, Helen Heyerdahl & Jostein Dahle. Faculty of Medicine, University of Oslo, P.O. Box 1074, Blindern, 0316, Oslo, Norway. › articles
Gap Junctional Intercellular Communication is not a Major ...
bioone.org
Jostein Dahle, Svein-Ole Mikalsen, Edgar Rivedal, and Harald B. Steen "Gap Junctional Intercellular Communication is not a Major Mediator in the Bystander ... › doi › abs
Nordic Nanovector - Crunchbase Company Profile & Funding
www.crunchbase.com
Jostein Dahle. CSO. Non-Management Management, Operations. 2 emails found. View contacts for Nordic Nanovector to access new leads and connect with ... › organization › nordic-na...
Related search requests for Jostein Dahle
| Arne Kolstad Helen Heyerdahl Johan Moan | Sebastian Patzke Harald Holte |
People Forename "Jostein" (723) Name "Dahle" (973) |
sorted by relevance / date